In March, U.S. Food and Drug Administration officials licensed a live, attenuated varicella vaccine for healthy children and adults who have not had chickenpox. The AAP policy statement, "Recommendations for the Use of Live Attenuated Varicella Vaccine," appeared in the May issue of Pediatrics. AAP Committee on Infectious Diseases member Steve Kohl, M.D., offers the following responses to pediatricians' questions about the vaccine.

This content is only available via PDF.
You do not currently have access to this content.